Back to Search
CONOR DASS, MD
MD
Emergency Medicine Physician
NPI: 1255955290IndividualAccepts Medicare
Education
OTHER
Class of 2020
Research & Publications (20)
c-Jun Is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasizing model.
PMID 18708361·Mol Cancer Res·2008
7-preclinical
c-Jun knockdown sensitizes osteosarcoma to doxorubicin.
PMID 18645001·Mol Cancer Ther·2008
7-preclinical
PEDF as an emerging therapeutic candidate for osteosarcoma.
PMID 19075591·Curr Cancer Drug Targets·2008
6-review
C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies.
PMID 18604982·Pharmazie·2008
6-review
Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy.
PMID 18497564·Cancer Biol Ther·2008
7-preclinical
Chitosan-mediated orally delivered nucleic acids: a gutful of gene therapy.
PMID 18446603·J Drug Target·2008
6-review
Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model.
PMID 18414033·Cancer Biol Ther·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 981150 NEBRASKA MEDICAL CTR
OMAHA, NE 68198 - Phone
- (402) 559-6802
Quick Facts
- NPI
- 1255955290
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile